Introduction
Leading pharmaceutical company has entered a strategic product development partnership with Kenox Pharmaceuticals to develop multiple nasal spray products for the US market.
Also Read: Brigade Enterprises: Stock jumps after signing agreement for residential development in Bengaluru
Share price movement of Strides Pharma
On September 9, 2025, Strides Pharma Science Ltd opened at ₹896.95, up 1.80% from its previous close of ₹881.05. The stock reached a high of ₹897.00 and a low of ₹878.25. By 12:04 PM, it traded at ₹878.85, with a market cap of ₹8,100.60 crore.
Strides Partners with Kenox to Expand Nasal Sprays
Strides Pharma Science Ltd announced a strategic product development partnership with Kenox Pharmaceuticals Inc. The agreement involves Strides’ subsidiary, Strides Pharma Global Pte. Limited, Singapore, collaborating with Kenox on nasal spray products.
The collaboration focuses on developing and filing multiple nasal spray products for the US market. Kenox will provide formulation and development expertise in Orally Inhaled and Nasal Drug Products (OINDPs) to support the partnership.
The partnership aims to accelerate the availability of affordable, high-quality nasal spray medicines across diverse therapeutic areas. Specific product details remain confidential, and the collaboration is expected to strengthen Strides’ nasal spray pipeline.
Ace investor holding in Strides Pharma
Mukul Mahavir Agrawal holds a 1.16% stake in Strides Pharma Science Ltd, owning 1,066,000 shares valued at ₹93.7 crore.
Stock performance of Strides Pharma for Period of 1 week, 6 months, and 1 year
Strides Pharma Science Ltd delivered a -1.62% return over the past week, gained 50.0% in the past six months, and rose 43.7% over the past year.
Also Read: Sudarshan Pharma: Stock hits upper circuit after signing agreement with Srigen Lifesciences
Shareholding pattern of Strides Pharma
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
| Promoter | 28.30% | 28.30% | 26.80% |
| FII | 28.00% | 28.30% | 28.50% |
| DII | 13.30% | 13.70% | 16.90% |
| Public | 30% | 30% | 27.80% |
About Strides Pharma
Strides Pharma Science Ltd (NSE: STAR) is a Bengaluru-based global pharmaceutical company. It operates in regulated and donor-funded markets, manufactures complex products, and has facilities in India, Italy, Kenya, and the United States.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
A: Strides Pharma Science Ltd share price rose after announcing a strategic nasal spray product development partnership with Kenox Pharmaceuticals Inc.
A: Mukul Mahavir Agrawal holds a 1.16% stake in Strides Pharma Science Ltd, owning 1,066,000 shares valued at ₹93.7 crore.
A: The 52-week high of Strides Pharma Science Ltd stock is ₹971.90, and the 52-week low is ₹530.70.


